FDA Approves Rituximab for Children with GPA & MPA
Iguratimod May Hold Promise for Treating Autoimmune Disease
Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4
Abx464 Enters Phase 2 Clinical Trials for RA in Europe
FDA Approves Ixekizumab for Treating Active Ankylosing Spondylitis
FDA Approves Upadacitinib for RA
Filgotinib Promising for RA
FDA Approves AbbVie’s New Rheumatoid Arthritis Drug
Otilimab Begins Phase 3 Clinical Studies for RA
- 1
- 2
- 3
- …
- 17
- Next Page »